2 Results for "

Host-directed therapy (HDT)

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "Host-directed therapy (HDT)" in MCE Product Catalog:

Cat. No.: HY-N7741
CAS No.: 67667-64-5
Synonyms: Dehydrozaluzanin C-derivative
Isozaluzanin C (Dehydrozaluzanin c-derivative) is an anti-inflammatory agent that can be isolated from Saussurea lappa and has immunomodulatory effects. Isozaluzanin C improves tissue damage (lung, kidney, and liver) and excessive inflammation in mice induced by LPS (HY-D1056) or CRKP infection. Isozaluzanin C can be used in the study of bacterial infections and sepsi .
loading...
    loading...
Cat. No.: HY-145931
CAS No.: 1228012-18-7
Purity:  98.41%
Target:  

mTOR Autophagy

Research Areas:  

Cancer

CC214-2 is an oral active and selective mTOR kinase inhibitor. CC214-2 targets to both of mTORC1 (pS6) and mTORC2 (pAktS473). CC214-2 induces autophagy, which is a potential target for host-directed therapy (HDT) in tuberculosis. CC214-2 exhibits synergistic bactericidal and sterilizing activity agasinst tuberculosis (TB), and shortens the treatment duration. CC214-2 also inhibits Rapamycin (HY-10219)-resistant signaling and the growth of glioblastomas in vitro and in vivo .
loading...
    loading...